CorVel (CRVL) Competitors $96.13 -1.86 (-1.90%) As of 12:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRVL vs. DGX, DVA, CHE, AMED, MD, AMN, CCRN, LH, APG, and ULSShould you be buying CorVel stock or one of its competitors? The main competitors of CorVel include Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), Amedisys (AMED), Pediatrix Medical Group (MD), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), APi Group (APG), and UL Solutions (ULS). CorVel vs. Its Competitors Quest Diagnostics DaVita Chemed Amedisys Pediatrix Medical Group AMN Healthcare Services Cross Country Healthcare Labcorp APi Group UL Solutions CorVel (NASDAQ:CRVL) and Quest Diagnostics (NYSE:DGX) are both health care services companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, profitability, analyst recommendations, institutional ownership, media sentiment, dividends, valuation and earnings. Does the media refer more to CRVL or DGX? In the previous week, Quest Diagnostics had 26 more articles in the media than CorVel. MarketBeat recorded 29 mentions for Quest Diagnostics and 3 mentions for CorVel. CorVel's average media sentiment score of 1.32 beat Quest Diagnostics' score of 1.04 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quest Diagnostics 14 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Positive Do analysts prefer CRVL or DGX? Quest Diagnostics has a consensus target price of $185.73, indicating a potential upside of 12.37%. Given Quest Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe Quest Diagnostics is more favorable than CorVel.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Quest Diagnostics 0 Sell rating(s) 7 Hold rating(s) 7 Buy rating(s) 2 Strong Buy rating(s) 2.69 Which has more volatility and risk, CRVL or DGX? CorVel has a beta of 0.98, meaning that its share price is 2% less volatile than the S&P 500. Comparatively, Quest Diagnostics has a beta of 0.49, meaning that its share price is 51% less volatile than the S&P 500. Which has higher earnings and valuation, CRVL or DGX? Quest Diagnostics has higher revenue and earnings than CorVel. Quest Diagnostics is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCorVel$895.59M5.52$95.17M$1.8452.24Quest Diagnostics$9.87B1.87$871M$7.9120.90 Do institutionals and insiders believe in CRVL or DGX? 51.4% of CorVel shares are owned by institutional investors. Comparatively, 88.1% of Quest Diagnostics shares are owned by institutional investors. 44.6% of CorVel shares are owned by insiders. Comparatively, 8.2% of Quest Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is CRVL or DGX more profitable? CorVel has a net margin of 10.63% compared to Quest Diagnostics' net margin of 8.81%. CorVel's return on equity of 32.55% beat Quest Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets CorVel10.63% 32.55% 18.22% Quest Diagnostics 8.81%15.11%6.65% SummaryQuest Diagnostics beats CorVel on 9 of the 17 factors compared between the two stocks. Get CorVel News Delivered to You Automatically Sign up to receive the latest news and ratings for CRVL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRVL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRVL vs. The Competition Export to ExcelMetricCorVelBUSINESS SVCS IndustryBusiness SectorNASDAQ ExchangeMarket Cap$4.95B$5.92B$14.99B$9.35BDividend YieldN/A3.04%2.71%4.02%P/E Ratio52.3422.2928.0819.71Price / Sales5.521.8846.1675.42Price / Cash40.2713.7125.4927.56Price / Book15.335.216.355.59Net Income$95.17M$150.49M$195.98M$257.73M7 Day Performance-3.71%-0.60%0.12%1.48%1 Month Performance-8.51%4.99%6.91%11.34%1 Year Performance7.73%53.19%24.94%16.16% CorVel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRVLCorVel1.0276 of 5 stars$96.13-1.9%N/A+10.2%$4.95B$895.59M52.345,075Positive NewsDGXQuest Diagnostics4.9594 of 5 stars$173.78-1.8%$185.73+6.9%+16.8%$19.75B$9.87B21.9756,000Positive NewsUpcoming EarningsDVADaVita4.4596 of 5 stars$142.71+0.1%$164.50+15.3%+1.3%$10.76B$12.82B14.1476,000Positive NewsCHEChemed4.9865 of 5 stars$461.20-2.5%$645.00+39.9%-13.7%$6.92B$2.49B22.4615,695AMEDAmedisys2.5965 of 5 stars$96.50+0.4%$100.75+4.4%-0.3%$3.15B$2.35B35.6119,000MDPediatrix Medical Group2.835 of 5 stars$13.44-2.5%$16.67+24.0%+77.6%$1.18B$2.01B-13.314,305Positive NewsAMNAMN Healthcare Services4.389 of 5 stars$21.23-3.1%$32.08+51.1%-58.4%$839.20M$2.98B-4.902,968CCRNCross Country Healthcare3.8858 of 5 stars$12.75-2.0%$17.93+40.6%-12.4%$426.51M$1.34B-24.068,205LHLabcorp4.6498 of 5 stars$257.78-1.6%$276.08+7.1%+21.1%$21.92B$13.01B29.8070,000Dividend AnnouncementAPGAPi Group2.8204 of 5 stars$34.20-0.4%$33.71-1.4%+36.5%$14.26B$7.02B111.5229,000Analyst UpgradeULSUL Solutions2.1563 of 5 stars$73.15+3.5%$69.43-5.1%+65.6%$14.17B$2.87B39.9315,094 Related Companies and Tools Related Companies DGX Alternatives DVA Alternatives CHE Alternatives AMED Alternatives MD Alternatives AMN Alternatives CCRN Alternatives LH Alternatives APG Alternatives ULS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRVL) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CorVel Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share CorVel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
